Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Cynata Therapeutics.
RELATED STOCKHEAD STORIES
News
Rise and Shine: What you need to know before the ASX opens
Health & Biotech
Who else on the ASX joins Mesoblast in the fight against ARDS and where are they at?
News
Last Orders: What you might have missed on the ASX today
Health & Biotech
Cynata stem cell technology a triumph: scientist
Health & Biotech
First patient with rare skin disorder receives Clinuvel drug
Health & Biotech
Aussie biotechs join crusade for COVID-19 cure
Health & Biotech
Dr Boreham’s Crucible: Dimerix not putting all its eggs in one basket
Health & Biotech
These are the life sciences small caps almost unscathed by COVID-19
Health & Biotech
Health Kick: Cynata’s stem cell therapy could be a game changer for COVID-19 patients
Health & Biotech
The healthcare winners and losers after COVID-19, and what comes next
Experts
Scopo’s health powerplays: Clinical trials are back
Stockhead TV
StockTalk: Biotechs set to boom with clinical trial floodgates open
Health & Biotech
COVID-19 treatments are a better bet than a vaccine
News
10 at 10: These ASX stocks are shooting through the skies this morning
Health & Biotech
ATO blocks biotech access to Jobkeeper wage subsidy
News
Rise and Shine: What you need to know before the ASX opens
Health & Biotech